Kindred Healthcare, Inc. (KND) Analysts See $0.16 EPS, Hebron Tech Company Limited (HEBT) Shorts Down By 34.02%

July 27, 2017 - By Adrian Erickson

Analysts expect Kindred Healthcare, Inc. (NYSE:KND) to report $0.16 EPS on August, 3 after the close.They anticipate $0.22 EPS change or 57.89% from last quarter’s $0.38 EPS. KND’s profit would be $13.70 million giving it 14.92 P/E if the $0.16 EPS is correct. After having $0.04 EPS previously, Kindred Healthcare, Inc.’s analysts see 300.00% EPS growth. It closed at $9.55 lastly. It is down 11.89% since July 27, 2016 and is downtrending. It has underperformed by 28.59% the S&P500.

Hebron Tech Company Limited (NASDAQ:HEBT) had a decrease of 34.02% in short interest. HEBT’s SI was 12,800 shares in July as released by FINRA. Its down 34.02% from 19,400 shares previously. With 47,800 avg volume, 0 days are for Hebron Tech Company Limited (NASDAQ:HEBT)’s short sellers to cover HEBT’s short positions. The SI to Hebron Tech Company Limited’s float is 0.36%. It closed at $3.29 lastly. It is down 0.00% since July 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 8 analysts covering Kindred Healthcare Inc. (NYSE:KND), 1 have Buy rating, 1 Sell and 6 Hold. Therefore 13% are positive. Kindred Healthcare Inc. had 22 analyst reports since September 2, 2015 according to SRatingsIntel. Stifel Nicolaus downgraded it to “Sell” rating and $5 target in Tuesday, November 8 report. On Thursday, October 1 the stock rating was initiated by Mizuho with “Neutral”. The stock of Kindred Healthcare, Inc. (NYSE:KND) earned “Neutral” rating by UBS on Tuesday, August 9. The stock of Kindred Healthcare, Inc. (NYSE:KND) has “Neutral” rating given on Wednesday, September 16 by JP Morgan. The rating was downgraded by Avondale on Friday, December 18 to “Mkt Perform”. The firm has “Neutral” rating given on Tuesday, November 8 by Mizuho. The company was maintained on Wednesday, November 11 by Mizuho. The company was maintained on Monday, March 7 by RBC Capital Markets. Mizuho maintained the stock with “Neutral” rating in Tuesday, February 28 report. RBC Capital Markets downgraded the stock to “Sector Perform” rating in Thursday, November 10 report.

Kindred Healthcare, Inc. is a healthcare services company. The company has market cap of $817.80 million. The Company, through its subsidiaries, operates transitional care hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States. It currently has negative earnings. The Firm operates through four divisions: the Kindred at Home division, the hospital division, the Kindred Rehabilitation Services division and the nursing center division.

Investors sentiment decreased to 1.06 in Q4 2016. Its down 0.89, from 1.95 in 2016Q3. It dropped, as 33 investors sold Kindred Healthcare, Inc. shares while 53 reduced holdings. 29 funds opened positions while 62 raised stakes. 78.68 million shares or 2.65% less from 80.82 million shares in 2016Q3 were reported. Suntrust Banks holds 0% in Kindred Healthcare, Inc. (NYSE:KND) or 14,941 shares. Financial Bank Of Nova Scotia invested in 0% or 97,719 shares. Morgan Stanley invested in 258,037 shares. Art Advsr Ltd Llc owns 96,700 shares or 0.05% of their US portfolio. 4,200 are held by Riverhead Mngmt Ltd Liability Corporation. Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in Kindred Healthcare, Inc. (NYSE:KND) for 11,414 shares. Barclays Public Ltd accumulated 24,973 shares. 555,117 were accumulated by Gotham Asset Mngmt Ltd. 25,623 were reported by Blackrock. Envestnet Asset invested 0% of its portfolio in Kindred Healthcare, Inc. (NYSE:KND). State Street reported 2.25M shares. Citadel Advsrs Ltd Liability Co, a Illinois-based fund reported 501,487 shares. New York-based Qs Investors Ltd Llc has invested 0.02% in Kindred Healthcare, Inc. (NYSE:KND). Clinton Grp owns 30,897 shares. North Tide Ltd Liability Co accumulated 5.7% or 4.25 million shares.

Hebron Technology Co., Ltd. is engaged in developing, manufacturing and providing customized installation of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries. The company has market cap of $48.35 million. The Firm offers its clients with pipeline design, installation, construction, ongoing maintenance services, as well as holistic solution services. It has a 6.68 P/E ratio. The Firm is also specialized in designing and implementing solutions services for industries with a need for sanitary fluid systems with product manufacture, installation services and after-sales services.